Traumatic Brain Injury News and Research

RSS
Traumatic brain injury (TBI), a form of acquired brain injury, occurs when a sudden trauma causes damage to the brain. TBI can result when the head suddenly and violently hits an object, or when an object pierces the skull and enters brain tissue. Symptoms of a TBI can be mild, moderate, or severe, depending on the extent of the damage to the brain. A person with a mild TBI may remain conscious or may experience a loss of consciousness for a few seconds or minutes. Other symptoms of mild TBI include headache, confusion, lightheadedness, dizziness, blurred vision or tired eyes, ringing in the ears, bad taste in the mouth, fatigue or lethargy, a change in sleep patterns, behavioral or mood changes, and trouble with memory, concentration, attention, or thinking. A person with a moderate or severe TBI may show these same symptoms, but may also have a headache that gets worse or does not go away, repeated vomiting or nausea, convulsions or seizures, an inability to awaken from sleep, dilation of one or both pupils of the eyes, slurred speech, weakness or numbness in the extremities, loss of coordination, and increased confusion, restlessness, or agitation.
First Edition: December 7, 2012

First Edition: December 7, 2012

Kessler Foundation to study effects of intellectual enrichment on cognitive decline in people with MS

Kessler Foundation to study effects of intellectual enrichment on cognitive decline in people with MS

Scientists identify novel mechanism by which ketogenic diet could delay effects of aging

Scientists identify novel mechanism by which ketogenic diet could delay effects of aging

Investigators describe process by which apoE4 protein promotes development of Alzheimer's

Investigators describe process by which apoE4 protein promotes development of Alzheimer's

Roe, Gingrey to lead GOP doctors caucus

Roe, Gingrey to lead GOP doctors caucus

Study describes 68 cases of chronic traumatic encephalopathy in athletes, military veterans

Study describes 68 cases of chronic traumatic encephalopathy in athletes, military veterans

NeuroVive announce results from CicloMulsion Phase I trial on cardiac reperfusion injury

NeuroVive announce results from CicloMulsion Phase I trial on cardiac reperfusion injury

December issue of Neurosurgical Focus explores sports-related concussions

December issue of Neurosurgical Focus explores sports-related concussions

Imaging window into future for brain injury patients

Imaging window into future for brain injury patients

Musical Moments for MS honors Kessler Foundation expert with Medical Excellence Award

Musical Moments for MS honors Kessler Foundation expert with Medical Excellence Award

Amarantus demonstrates excellent diffusion profile of MANF in the striatum of rat brains

Amarantus demonstrates excellent diffusion profile of MANF in the striatum of rat brains

Study identifies fractional anisotropy as predictor of brain damage after TBI

Study identifies fractional anisotropy as predictor of brain damage after TBI

Official stats underestimate brain injury

Official stats underestimate brain injury

Traumatic brain injury incidence could be six times higher than previously estimated

Traumatic brain injury incidence could be six times higher than previously estimated

Citicoline not superior to placebo in treating traumatic brain injury

Citicoline not superior to placebo in treating traumatic brain injury

MRI reveals changes in brains of people with post-concussion syndrome

MRI reveals changes in brains of people with post-concussion syndrome

TBI, age-related dementia and stroke fuel neurologic disability in India

TBI, age-related dementia and stroke fuel neurologic disability in India

Study provides first picture of college enrollment and STEM participation for young adults with ASD

Study provides first picture of college enrollment and STEM participation for young adults with ASD

Breakthrough treatment for survivors of traumatic brain injury

Breakthrough treatment for survivors of traumatic brain injury

Brevetoxin-2 stimulates nerve cell growth and plasticity in cultured mouse neurons

Brevetoxin-2 stimulates nerve cell growth and plasticity in cultured mouse neurons

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.